Download PDF

1. Company Snapshot

1.a. Company Description

Retractable Technologies, Inc.designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally.It offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.


The company distributes its products through general line and specialty distributors, as well as through international distributors; and a direct marketing network.Retractable Technologies, Inc.was incorporated in 1994 and is headquartered in Little Elm, Texas.

Show Full description

1.b. Last Insights on RVP

Retractable Technologies, Inc.'s recent positive drivers include the withdrawal of its complaint in the United States Court of International Trade, leading to the dismissal of the case on January 8, 2025. This resolution removes uncertainty and potential costs associated with the 100% tariff on syringes and needles imported from China. Additionally, the company's management has expressed confidence in its initial investigations, suggesting a favorable outcome. This development, combined with a potential rebound in demand for medical supplies, may support the company's growth prospects.

1.c. Company Highlights

2. Transcript Summary

Unfortunately this company is not part of our coverage yet. But as part of your subscription plan you can request it by clicking just below and we'll process.

Request Coverage

3. NewsRoom

Card image cap

RVP Stock Rises Post Q3 Earnings Despite Tariff and Cost Pressures

Nov -20

Source: zacks.com

Card image cap

Retractable Technologies, Inc. Results for the Periods Ended September 30, 2025

Nov -14

Source: businesswire.com

Card image cap

Retractable Technologies, Inc. Receives Innovative Technology Designation from Vizient for EasyPoint Blood Collection Tube Holder with Needle

Nov -14

Source: businesswire.com

Card image cap

Retractable Technologies Stock Gains Following Q2 Earnings Growth

Aug -21

Source: zacks.com

Card image cap

Retractable Technologies, Inc. Results for the Periods Ended June 30, 2025

Aug -14

Source: businesswire.com

Card image cap

Retractable Technologies, Inc. Announces Reduction in Its Manufacturing Workforce

Jul -23

Source: businesswire.com

Card image cap

Zacks Initiates Coverage of Retractable Technologies With Underperform Recommendation

Jun -19

Source: zacks.com

Card image cap

Retractable Technologies, Inc. Results for the Period Ended March 31, 2025

May -15

Source: businesswire.com

4. Business Breakdown

4.a. Revenues by Country

4.b. Revenues by Segment

5. Expected revenues mid-term growth (8.42%)

6. Segments

Syringes

Expected Growth: 8.5%

Growing demand for safety-engineered medical devices, increasing awareness about needlestick injuries, and government regulations promoting the use of safety syringes drive the market growth.

EasyPoint Needles

Expected Growth: 8.1%

Growing demand for safety-engineered needles, increasing awareness about needlestick injuries, and government regulations promoting the use of safety needles drive the growth of the EasyPoint Needles market.

Blood Collection

Expected Growth: 8.1%

Growing demand for safety-engineered devices, increasing awareness of needlestick injuries and bloodborne pathogen transmission, and advancements in medical technology are expected to drive the growth of the blood collection market.

Other

Expected Growth: 5.5%

The 'Other' segment's growth is driven by increasing demand for licensing agreements and non-medical products, fueled by advancements in technology and growing partnerships.

7. Detailed Products

VanishPoint

A line of safety syringes designed to reduce the risk of needlestick injuries and prevent reuse.

PatientSafe

A syringe designed for patient safety, featuring a retractable needle to prevent needlestick injuries.

VanishPoint Blood Collection

A blood collection device with a retractable needle, designed to reduce the risk of needlestick injuries.

Retractable IV Catheter

A safety IV catheter with a retractable needle, designed to reduce the risk of needlestick injuries.

8. Retractable Technologies, Inc.'s Porter Forces

Forces Ranking

Threat Of Substitutes

Retractable Technologies, Inc. has a moderate threat of substitutes due to the presence of alternative products in the market, but the company's patented technology and high-quality products help to mitigate this threat.

Bargaining Power Of Customers

Retractable Technologies, Inc. has a low bargaining power of customers due to the company's strong brand reputation and the lack of concentration in the buyer's market.

Bargaining Power Of Suppliers

Retractable Technologies, Inc. has a moderate bargaining power of suppliers due to the presence of multiple suppliers in the market, but the company's long-term contracts and strategic partnerships help to mitigate this threat.

Threat Of New Entrants

Retractable Technologies, Inc. has a high threat of new entrants due to the low barriers to entry in the market and the attractiveness of the industry, but the company's patented technology and strong brand reputation help to deter new entrants.

Intensity Of Rivalry

Retractable Technologies, Inc. operates in a highly competitive market with several established players, leading to a high intensity of rivalry among competitors.

9. SWOT Analysis

Strength

Weaknesses

Opportunities

Threats

10. Capital Structure

10.a. Balance Sheet

10.b. Weighted Average Cost of capital

Value
Debt Weight 1.53%
Debt Cost 12.54%
Equity Weight 98.47%
Equity Cost 14.45%
WACC 14.42%
Leverage 1.55%

11. Quality Control: Retractable Technologies, Inc. passed 4 out of 9 key points

12.a Historical Valuation

12.b Price/Earnings Ratio

12.c Margin Valuation

12.d Peers Valuation

Peers Group Analysis

Stock-Card
AtriCure

A-Score: 4.5/10

Value: 5.0

Growth: 6.0

Quality: 4.0

Yield: 0.0

Momentum: 7.5

Volatility: 4.3

1-Year Total Return ->

View Full Report
Stock-Card
Retractable Technologies

A-Score: 4.0/10

Value: 9.4

Growth: 0.6

Quality: 3.9

Yield: 0.0

Momentum: 6.5

Volatility: 3.7

1-Year Total Return ->

View Full Report
Stock-Card
BioLife Solutions

A-Score: 3.9/10

Value: 4.4

Growth: 4.7

Quality: 4.7

Yield: 0.0

Momentum: 6.5

Volatility: 3.0

1-Year Total Return ->

View Full Report
Stock-Card
Stereotaxis

A-Score: 3.8/10

Value: 6.2

Growth: 1.7

Quality: 3.7

Yield: 0.0

Momentum: 9.0

Volatility: 2.3

1-Year Total Return ->

View Full Report
Stock-Card
Sanara MedTech

A-Score: 3.2/10

Value: 3.0

Growth: 6.8

Quality: 2.3

Yield: 0.0

Momentum: 4.0

Volatility: 3.0

1-Year Total Return ->

View Full Report
Stock-Card
Ekso Bionics

A-Score: 3.0/10

Value: 8.6

Growth: 4.4

Quality: 3.9

Yield: 0.0

Momentum: 0.0

Volatility: 1.0

1-Year Total Return ->

View Full Report

Peers Metrics

12.e Scoring Insights

12.f DCF BETA

Parameters

Short Term Growth

Short term Time

Long-Term Growth

WACC

Target Price

0.82$

Current Price

0.82$

Potential

-0.00%

Expected Cash-Flows